Scholar Rock Holding (SRRK) FCF Margin (QoQ) (2019 - 2022)
Analysis
Scholar Rock Holding (SRRK) FCF Margin (QoQ) (2019 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Scholar Rock Holding | 7.26 Bn | 7.26 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 68,537.00 |
| Dec 31, 2021 | -13,068.00 |
| Sep 30, 2021 | 2,947.00 |
| Jun 30, 2021 | -10,082.00 |
| Mar 31, 2021 | 1,744.00 |
| Dec 31, 2020 | 17,788.00 |
| Sep 30, 2020 | -29,392.00 |
| Jun 30, 2020 | -55,216.00 |
| Mar 31, 2020 | 26,943.00 |
| Dec 31, 2019 | 9,264.00 |
| Sep 30, 2019 | 1,323.00 |
| Jun 30, 2019 | 18,448.00 |